India's government will lower prices on 137 cancer drugs from next month. The move follows a Supreme Court case filed in 2022 by a retired bank clerk who could not afford treatment. The court called drug mark-ups "extortion."
Why it matters: Millions of poorer patients could afford treatment they previously skipped or paid for with ruinous debt.
India's government moved to reduce prices of 137 cancer drugs from next month after the Supreme Court ruled that mark-ups amounted to 'extortion'. The case was filed in 2022 by a retired bank clerk who could not afford her medicine.
Why it matters: Lower prices could make treatment affordable for millions of patients who face financial ruin from a diagnosis.